Who is sponsoring NCT06710951?

NCT06710951 is sponsored by José Gerardo García Aguirre.

What drugs are being tested in NCT06710951?

Interventions in NCT06710951: Change of normal concentration of povidone-iodine 5% to 1%.

Is NCT06710951 still recruiting?

NCT06710951 is currently completed. Last updated 29 November 2024.

Last reviewed 2024-11-29 · How we verify

NCT06710951: anti-VEGF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF

Completed NA Last updated 29 November 2024

What this trial tests

NA trial testing Change of normal concentration of povidone-iodine 5% to 1% in Dry Eye in 88 participants. Completed in 30 June 2022.

Timeline

15 November 2021

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	José Gerardo García Aguirre
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	88
Start date	15 November 2021
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Mexico

Drugs / interventions tested

Change of normal concentration of povidone-iodine 5% to 1%

Conditions studied

Dry Eye — all drugs for Dry Eye →

Sponsor

José Gerardo García Aguirre

Who can join

45 and older, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective and subjective comparison between the use of povidone-iodine 1% vs 5% as antiseptic in patients that need anti-VEGF intravitreal injection

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dry Eye

Currently open trials in the same condition.

NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06710951 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by José Gerardo García Aguirre
Last refreshed: 29 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06710951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing